Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target ...

In April 2026, Gyre initiated its adaptive Phase 2/3 clinical trial in oncology-related pulmonary complications, with the first patient enrolled. The trial is evaluating pirfenidone for ...

Initial CX-801 clinical data in advanced melanoma, both as monotherapy and in combination with KEYTRUDA, are expected by the end of 2026, with observed tolerability at doses surpassing the approved ...

Hosted virtual Analyst Day showcasing lead program KRRO-121’s potential to be a first-in-class transformational treatment for hyperammonemia in patients with urea cycle disorders (UCDs) and hepatic ...

What buffers do: Buffers limit pH changes by using a weak acid and conjugate base pair to neutralize added acids or bases through reversible reactions. Why pKa matters: A buffer’s pKa determines the ...

Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target approachesPhase 1 initiation expected in the second half of 2026 ...

Find out which foreign language is easiest for English speakers and what makes some languages faster, smoother, and less stressful to learn.

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

A viral TikTok video of a South African man living in China speaking Xhosa to a Chinese woman left social media users ...

Researchers developed a photocatalytic covalent organic framework that selectively captures gold from electronic waste ...

ZYNLONTA combo trials in r/r DLBCL, key LOTIS-5 data Q2 2026, strong ORR/CR, cash to 2028—read now. Click for this ADCT ...

Good afternoon, everyone, and welcome to Gilead's First Quarter 2026 Earnings Conference Call. My name is Rebecca, and I'll be today's host. [Operator Instructions] Now I'll hand the call over to ...